Superficial accumulation of plasminogen during plasma clot lysis
- PMID: 7671373
- DOI: 10.1161/01.cir.92.7.1883
Superficial accumulation of plasminogen during plasma clot lysis
Abstract
Background: Binding of plasminogen to partially degraded fibrin is an important step in fibrinolysis, influencing its rate and fibrin specificity. Little is known about the spatial distribution of plasminogen and of plasminogen-binding sites inside thrombi during lysis. In the present study, we investigated this problem, which is important for a better understanding of the local regulation of fibrinolysis and the rate-limiting factors of therapeutic thrombolysis.
Methods and results: An experimental system was used that allowed continuous visualization and quantification by fluorescence microscopy of the spatial distribution of fluorescein-labeled plasminogen inside and outside model thrombi. Strong superficial accumulation of plasminogen was observed during lysis of a plasma clot induced by tissue-type or urokinase-type plasminogen activators in the surrounding plasma. A distinctly visible plasminogen-accumulating shell moved continuously with the reducing surface of the clot. The accumulation decreased in conditions of exhaustive activation of plasminogen in the outer plasma. It was found in a purified system that a thin superficial layer (approximately 50 microns wide) of a plasmin-treated fibrin clot exposes about 2.5 plasminogen-binding sites per fibrin monomer with a Kd of 2.2 mumol/L. At a physiological concentration of plasminogen (1.5 mumol/L) in the outer medium, plasminogen was concentrated about 10-fold in this layer. The binding was dose-dependently inhibited by epsilon-aminocaproic acid.
Conclusions: We conclude that the generation of potent surface-associated plasminogen-binding sites during thrombolysis results in a strikingly high plasminogen concentration at the dynamically changing surface of a lysing clot. The necessity of a continuous plasminogen supply from the plasma supports the use of fibrin-specific and plasminogen-sparing agents for thrombolytic therapy.
Similar articles
-
Rearrangements of the fibrin network and spatial distribution of fibrinolytic components during plasma clot lysis. Study with confocal microscopy.J Biol Chem. 1996 Jan 26;271(4):2133-8. doi: 10.1074/jbc.271.4.2133. J Biol Chem. 1996. PMID: 8567670
-
Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.J Clin Invest. 1988 Mar;81(3):853-9. doi: 10.1172/JCI113394. J Clin Invest. 1988. PMID: 2963831 Free PMC article.
-
Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.Thromb Haemost. 1995 Aug;74(2):711-7. Thromb Haemost. 1995. PMID: 8585011
-
Activation of the fibrinolytic system.Cardiol Clin. 1987 Feb;5(1):13-9. Cardiol Clin. 1987. PMID: 3103919 Review.
-
Activation of fibrin-bound plasminogen by pro-urokinase and its complementariness with that by tissue plasminogen activator.Enzyme. 1988;40(2-3):97-108. doi: 10.1159/000469151. Enzyme. 1988. PMID: 2971533 Review.
Cited by
-
Human complement receptor type 1-directed loading of tissue plasminogen activator on circulating erythrocytes for prophylactic fibrinolysis.Blood. 2006 Sep 15;108(6):1895-902. doi: 10.1182/blood-2005-11-012336. Epub 2006 May 30. Blood. 2006. PMID: 16735601 Free PMC article.
-
Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm.ACS Nano. 2014 May 27;8(5):4100-32. doi: 10.1021/nn500136z. Epub 2014 May 7. ACS Nano. 2014. PMID: 24787360 Free PMC article. Review.
-
Vascular targeting of antithrombotic agents.IUBMB Life. 2011 Aug;63(8):632-9. doi: 10.1002/iub.474. Epub 2011 Jul 15. IUBMB Life. 2011. PMID: 21766410 Free PMC article. Review.
-
Annexin A2: a tissue plasminogen activator amplifier for thrombolytic stroke therapy.Stroke. 2010 Oct;41(10 Suppl):S54-8. doi: 10.1161/STROKEAHA.110.596106. Stroke. 2010. PMID: 20876506 Free PMC article.
-
Interventional Therapy for Upper Extremity Deep Vein Thrombosis.Semin Intervent Radiol. 2017 Mar;34(1):54-60. doi: 10.1055/s-0036-1597764. Semin Intervent Radiol. 2017. PMID: 28265130 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources